| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,350 |
3,669 |
$137K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,405 |
1,080 |
$38K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
865 |
649 |
$31K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
129 |
116 |
$12K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
141 |
133 |
$10K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
179 |
111 |
$10K |
| 93000 |
|
2,343 |
1,688 |
$8K |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
179 |
114 |
$5K |
| 93015 |
|
311 |
209 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
143 |
131 |
$3K |
| 99401 |
|
150 |
141 |
$3K |
| 0001A |
|
52 |
51 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
160 |
153 |
$2K |
| 99443 |
|
77 |
66 |
$2K |
| 0002A |
|
41 |
41 |
$2K |
| J2785 |
Injection, regadenoson, 0.1 mg |
22 |
14 |
$1K |
| 99051 |
|
457 |
379 |
$1K |
| 99215 |
Prolong outpt/office vis |
64 |
59 |
$1K |
| 99490 |
Ccm add 20min |
188 |
167 |
$1K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
94 |
54 |
$831.45 |
| 90688 |
|
235 |
187 |
$800.48 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
63 |
50 |
$713.38 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
140 |
83 |
$614.38 |
| 99000 |
|
329 |
271 |
$589.06 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
99 |
54 |
$395.61 |
| 81002 |
|
390 |
296 |
$363.72 |
| 36415 |
Collection of venous blood by venipuncture |
95 |
83 |
$123.59 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
13 |
13 |
$55.77 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
53 |
37 |
$43.00 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
59 |
38 |
$33.35 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
25 |
14 |
$23.46 |
| G0328 |
Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous |
41 |
24 |
$0.78 |
| 3017F |
|
94 |
59 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
713 |
424 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
390 |
226 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
120 |
86 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
727 |
430 |
$0.00 |
| 1036F |
|
21 |
13 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
19 |
12 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
499 |
292 |
$0.00 |
| 4040F |
|
703 |
413 |
$0.00 |
| 3288F |
|
701 |
411 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
107 |
63 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
741 |
437 |
$0.00 |
| G8598 |
Aspirin or another antiplatelet therapy used |
213 |
115 |
$0.00 |